TPG Inc. Chief Financial Officer Axel Andre received grants of 164,908 restricted stock units and 164,908 performance stock units on August 17, 2026, according to a Form 4 filed with the SEC on August 19, 2026.
Peter Henry Oey, Chief Financial Officer of Grab Holdings Ltd, filed a Form 4 on August 19, 2026, disclosing the sale of 50,000 Class A Ordinary Shares on August 17, 2026, pursuant to a pre-established Rule 10b5-1(c) trading plan.
Matthew Robert Pollak, Principal Accounting Officer of Employers Holdings, Inc. (NYSE:EIG), filed a statement of changes in beneficial ownership on August 19, 2026, reporting a transaction dated August 17, 2026.
A beneficial ownership change report for Forestar Group Inc. was filed on August 19, 2026, disclosing a sale of common stock by director Lisa H. Jamieson on August 18, 2026.
Evan Lippman, Executive Vice President of Business Development at Teva Pharmaceutical Industries Ltd., filed a Form 4 on August 19, 2026, reporting the sale of 18,600 ordinary shares on August 17, 2026, pursuant to a pre-established Rule 10b5-1 trading plan.
A Form 4 filed on August 19, 2026 disclosed that Shachar Erez, a director of Riskified Ltd. (NYSE:RSKD), reported the sale of Class A Ordinary Shares on August 17 and August 18, 2026, conducted pursuant to a Rule 10b5-1 trading plan.
Merck & Co. is one of the largest global pharmaceutical companies, with a diversified portfolio spanning oncology, vaccines, and other therapeutic areas. As a large-cap pharma name, MRK's price action tends to be driven by a mix of steady fundamental developments — drug approvals, …
Maravai LifeSciences Holdings is a life sciences company providing critical products used in nucleic acid production andBiologicssafety testing, including reagents and technologies that support mRNA-basedVaccineand therapeutic development. As a tools and reagents supplier rather than a clinical-stage drug developer, MRVI's price action tends to …
Key TakeawaysSana Biotechnology surged 12.95% (+$0.47) on Thursday to close at $4.10, breaking out decisively above both its 21-day EMA ($3.56) and 63-day EMA ($3.43) after months of trading below these key trend lines.The rally came onVolumeof 5.9 million shares, a sharp pickup versus …
BioNTech SE is a German biopharmaceutical company best known for its mRNA-basedVaccineand therapeutic platform, with an expanding pipeline spanning oncology, infectious disease, and other areas beyond its original COVID-19 vaccineFranchisedeveloped with Pfizer. As with many biopharma names of its scale, BNTX's share price has …